When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Merck & Co. - Wikipedia

   en.wikipedia.org/wiki/Merck_&_Co.

   Merck & Co. traces its origins to its former German parent company Merck Group, which was established by the Merck family in 1668 when Friedrich Jacob Merck purchased a drug store in Darmstadt. [ 27 ] [ 28 ] In 1827, Merck Group evolved from a pharmacy to a drug manufacturer company with the commercial manufacture of morphine . [ 29 ]

3. Merck Group - Wikipedia

   en.wikipedia.org/wiki/Merck_Group

   The American pharmaceutical company Merck & Co. was established as a subsidiary of Merck in 1891, but was nationalized by the United States in 1917, before being privatized again when George W. Merck, a member of an American branch of the Merck family, repurchased the stock in 1919. [9]

4. Drugmakers to raise US prices on over 250 medicines starting ...

   www.aol.com/news/drugmakers-raise-us-prices-over...

   Merck & Co plans to cut the list price of its heavily discounted diabetes drugs Januvia and Janumet "to align the list price more closely to the net price." ... The company raised prices around 15 ...

5. Merck family - Wikipedia

   en.wikipedia.org/wiki/Merck_family

   Coat of arms of the Darmstadt branch of the Merck family Coat of arms of the Hamburg branch of the Merck family Engel-Apotheke. The Merck family is a German noble family of industrialists and bankers, known for establishing the world's oldest pharmaceutical company Merck, its American former subsidiary Merck & Co. (MSD), which is now an independent company, as well as the Hamburg merchant bank ...

6. Merck nears $1.3 billion cash deal for eye-drug company ... - AOL

   www.aol.com/news/merck-nears-1-3-billion...

   (Reuters) -Merck & Co is nearing a $1.3 billion cash deal to buy ophthalmology biotechnology company Eyebiotech in an agreement that could see an additional $1.7 billion in milestone payments, the ...

7. Merck to buy eye-focused drug developer EyeBio for as ... - AOL

   www.aol.com/news/merck-acquire-eye-drug-company...

   (Reuters) -Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion, as it looks to diversify its portfolio of experimental drugs with treatments for eye diseases.